Epidemiological Study to Evaluate Adherence to Treatment in Bipolar Disorder: Adherence Study
1 other identifier
observational
300
1 country
24
Brief Summary
The purpose of this study is to estimate adherence to treatment in bipolar patients, to characterize patients based on adherence degree and to describe the variables linked to poor adherence to treatment in real-life practice.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2009
Shorter than P25 for all trials
24 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 23, 2009
CompletedFirst Posted
Study publicly available on registry
June 25, 2009
CompletedStudy Start
First participant enrolled
July 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2009
CompletedOctober 30, 2009
October 1, 2009
June 23, 2009
October 29, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Morisky-Green Scale
Once, at the visit moment
Drug Attitude Inventory Scale (DAI-10)
Once, at the visit moment
Secondary Outcomes (2)
Clinical Global Impressions for Bipolar illness-modified (CGI-BP-M)
Once, at the visit moment
Functioning Assessment Short Test (FAST)
Once, at the visit moment
Study Arms (1)
1
Patients diagnosed with bipolar disorder I or II (DSM-IV) in ambulatory settings
Eligibility Criteria
Patients diagnosed with bipolar disorder I or II (DSM-IV) in ambulatory settings
You may qualify if:
- Patients diagnosed with bipolar disorder I or II DSM-IV
- Patients treated with at least one oral antipsychotic
- Subjects able to read and write
You may not qualify if:
- Patients participating in clinical trials
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- AstraZenecalead
Study Sites (24)
Research Site
Las Palmas, Gran Canarias, Spain
Research Site
Calahorra, La Rioja, Spain
Research Site
Langreo, Principality of Asturias, Spain
Research Site
San Cristóbal de La Laguna, Tenerife, Spain
Research Site
Alicante, Spain
Research Site
Almería, Spain
Research Site
Badajoz, Spain
Research Site
Barcelona, Spain
Research Site
Córdoba, Spain
Research Site
Elche, Spain
Research Site
León, Spain
Research Site
Lleida, Spain
Research Site
Madrid, Spain
Research Site
Málaga, Spain
Research Site
Murcia, Spain
Research Site
Ourense, Spain
Research Site
Palma de Mallorca, Spain
Research Site
Salamanca, Spain
Research Site
Seville, Spain
Research Site
Toledo, Spain
Research Site
Valencia, Spain
Research Site
Valladolid, Spain
Research Site
Vitoria-Gasteiz, Spain
Research Site
Zaragoza, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Elisa Gil
AstraZeneca Spain EpidemiologyValue Demonstration Unit
Study Design
- Study Type
- observational
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
June 23, 2009
First Posted
June 25, 2009
Study Start
July 1, 2009
Study Completion
October 1, 2009
Last Updated
October 30, 2009
Record last verified: 2009-10